Laboratory Response to Anthrax Bioterrorism, New York City, 2001

In October 2001, the greater New York City Metropolitan Area was the scene of a bioterrorism attack. The scale of the public response to this attack was not foreseen and threatened to overwhelm the Bioterrorism Response Laboratory’s (BTRL) ability to process and test environmental samples. In a joint effort with the Centers for Disease Control and Prevention and the cooperation of the Department of Defense, a massive effort was launched to maintain and sustain the laboratory response and return test results in a timely fashion. This effort was largely successful. The development and expansion of the facility are described, as are the special needs of a BTRL. The establishment of a Laboratory Bioterrorism Command Center and protocols for sample intake, processing, reporting, security, testing, staffing, and quality assurance and quality control are also described.

[1]  Gina Pugliese,et al.  Anthrax as a Biological Weapon: Medical and Public Health Management , 1999 .

[2]  T J Cieslak,et al.  Clinical recognition and management of patients exposed to biological warfare agents. , 1997, Clinics in laboratory medicine.

[3]  P. Jahrling,et al.  Clinical recognition and management of patients exposed to biological warfare agents. , 1997, JAMA.

[4]  Henry D. Isenberg,et al.  Manual of Clinical Microbiology , 1991 .

[5]  Aponte Deborah A. Adams Gerald Jones Willie J. Anderson D Connor,et al.  Update: Investigation of bioterrorism-related anthrax and interim guidelines for clinical evaluation of persons with possible anthrax. , 2001, MMWR. Morbidity and mortality weekly report.

[6]  W. Emmett Barkley,et al.  Biosafety in microbiological and biomedical laboratories , 1984 .

[7]  Albert Balows,et al.  Manual of Clinical Microbiology, 7th ed. , 2000 .

[8]  A. Fine,et al.  Lessons from the West Nile viral encephalitis outbreak in New York City, 1999: implications for bioterrorism preparedness. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Update: Investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001. , 2001, MMWR. Morbidity and mortality weekly report.

[10]  Philip K. Russell,et al.  Smallpox as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. , 1999, JAMA.